Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-26

Clinical Trial Update: Clinical Trial of Enterovirus 71(EV71) Inactivated Vaccine in Children Aged 36-71 Months [Phase 3]

View source ↗

Summary

Phase 3 trial update for an inactivated EV71 vaccine in children 36-71 months completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enterovirus 71 Inactivated Vaccine (Enterovirus 71 inactivated vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 3 | Status: COMPLETED